For the quarter ending 2025-12-31, NNE had $374,280,349 increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | -6,516,279 | -8,050,410 | -32,016,666 |
| Amortization of right-of-use assets | 83,462 | 81,348 | 214,228 |
| Depreciation | 208,408 | 207,309 | 147,853 |
| Equity-based compensation | 2,072,690 | 1,369,373 | 17,454,842 |
| Bank revaluation | 731 | - | - |
| Change in fair value of contingent consideration | -727,500 | - | - |
| Due to related parties | - | -41,667 | 16,667 |
| Unrealized gain on marketable securities | -122,838 | - | - |
| Contingent liability | - | - | 0 |
| Deposits | - | -100,000 | 384,000 |
| Gain on settlement on accounts receivable | 152,515 | - | - |
| Changes in fair value of contingent liability | - | 203,500 | 1,004,000 |
| Accounts receivable | 86,381 | 0 | 250,000 |
| Prepaid expenses | 112,028 | -517,223 | 586,137 |
| Accounts payable and accrued liabilities | 1,226,110 | 717,142 | -164,027 |
| R&d acquisition paid in equity | - | - | 0 |
| Lease liabilities | -109,376 | -12,272 | -150,269 |
| Net cash used in operating activities | -3,989,840 | -4,908,454 | -14,713,509 |
| In-process research and development | - | 0 | 9,075,045 |
| Deposits | 1,604,766 | - | - |
| Additions to property, plant and equipment | - | 4,647,858 | 3,801,474 |
| Construction-in-progress | 1,453,915 | - | - |
| Net cash used in investing activities | -3,058,681 | -4,647,858 | -12,876,519 |
| Proceeds from common stock issuances | 400,000,033 | 0 | 206,400,015 |
| Offering costs | 21,520,711 | 0 | 15,076,556 |
| Proceeds from exercise of warrants | 2,445,048 | 2,818,989 | 15,657,187 |
| Proceeds from exercise of stock options | 540,000 | 120,000 | 2,284,500 |
| Payment of deferred offering costs | 135,500 | 300,000 | - |
| Net cash provided by financing activities | 381,328,870 | 2,638,989 | 209,265,146 |
| Net increase in cash | - | -6,917,323 | 181,675,118 |
| Net increase in cash and cash equivalents | 374,280,349 | - | - |
| Cash and cash equivalents at beginning of period | 203,265,052 | 28,507,257 | - |
| Effect of exchange rate changes on cash | -11,452 | - | - |
| Cash and cash equivalents at end of period | 577,533,949 | 203,265,052 | - |
Nano Nuclear Energy Inc. (NNE)
Nano Nuclear Energy Inc. (NNE)